Unique, practical knowledge for nurses responsible for daily management of patients with cardiovascular disease, diabetes and related conditions.

New drugs and where they fit in the treatment algorithm

Publication date: Tuesday, 27 October 2009
Contributor(s): Professor Mike Kirby

In May 2009, NICE published recommendations on the use of newer agents for the control of blood glucose in type 2 diabetes. This guideline provides a partial update for NICE Clinical Guideline 66 on the management of type 2 diabetes that was published last year. These newer agents include the dipeptidyl peptidase-4 (DPP-4) inhibitors, thiazolidinediones (TZDs), the glucagon-like peptide-1 (GLP-1) mimetic exenatide and the long-acting insulin analogues (insulin detemir and insulin glargine).

Topics covered:
Category: Editorial
Edition: Volume 6, Number 2, Jul-Aug-Sep 2009
Print edition page(s): S4-S5
Contributor(s): Professor Mike Kirby

Article search and filter